TOWA PHARMACEUTICAL CO.,LTD. (4553)

Market cap
¥220.2B
P/E ratio
11.9x
Towa Pharmaceutical manufactures and sells generic drugs to hospitals and distributors in Japan, Europe, and North America through its own facilities and subsidiaries.
Period EndOperating margin (%) YoY (%)
Mar 31, 20259+15.64%
Mar 31, 20247.7+193.26%
Mar 31, 20232.6-77.23%
Mar 31, 202211.6-9.84%
Mar 31, 202112.9-12.05%
Mar 31, 202014.6-3.74%
Mar 31, 201915.2+21.91%
Mar 31, 201812.5+54.11%
Mar 31, 20178.1-40.36%
Mar 31, 201613.6-12.74%
Mar 31, 201515.5
AI Chat